2 completed. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
Follow Servier: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of OSE-127 in Healthy Subjects OSE-127, Placebo - Healthy Subjects | Phase 1 | Completed | OSE Immunotherapeutics | 63 | 2018-12-19 | 2019-12-12 |
| Pharmacokinetics of AGO178 in Participants With Liver Impairment AGO178 - Hepatic Impairment | Phase 1 | Completed | Novartis Pharmaceuticals | 32 | 2011-02-08 | 2021-05-11 |
Colitis, Ulcerative (1) · Inflammatory Bowel Diseases (1)
agomelatine (1)
Belgium (1) · United States (1)
2018 (1)